Filing Details

Accession Number:
0000874015-19-000034
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-02-05 18:05:38
Reporting Period:
2019-02-01
Accepted Time:
2019-02-05 18:05:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
874015 Ionis Pharmaceuticals Inc IONS Pharmaceutical Preparations (2834) 330336973
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1564926 R. Patrick O'neil C/O Ionis Pharmaceuticals, Inc.
2855 Gazelle Court
Carlsbad CA 92010
Svp Legal & General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-02-01 4,000 $39.87 23,673 No 4 M Direct
Common Stock Disposition 2019-02-01 4,000 $58.29 19,673 No 4 S Direct
Common Stock Acquisiton 2019-02-05 15,600 $39.87 35,273 No 4 M Direct
Common Stock Disposition 2019-02-05 15,600 $59.50 19,673 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Acquisiton 2019-02-01 4,000 $0.00 4,000 $39.87
Common Stock Employee Stock Option (right to buy) Acquisiton 2019-02-05 15,600 $0.00 15,600 $39.87
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
23,875 2018-01-02 2021-01-01 No 4 M Direct
8,275 2018-01-02 2021-01-01 No 4 M Direct
Footnotes
  1. Acquired as a result of exercising a stock option pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on 8/29/2018.